GSK has developed a new propellant technology for inhaler devices that drastically reduces their use of greenhouse gases, which perhaps surprisingly account for nearly half (49%) of the group’s ...

Novartis and Qualcomm are to develop a 'smart' COPD inhaler to allow patients to ... plans by Novartis's rivals in the respiratory field, GlaxoSmithKline (GSK) and Boehringer Ingelheim (BI ...

Teva Pharmaceutical Industries Ltd. ADR 1.11% $24.97B ...

After hours: January 17 at 7:25:46 PM EST Loading Chart for GSK ...

The presence of propellant in the metered dose inhalers (MDIs) makes it challenging to identify when the inhaler is empty ... Competing interests PN has received speaker's fee for talks in severe ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

A roundup of news briefs and calendar events from around coastal Orange County, this week from the communities of Newport Beach, Costa Mesa, Irvine and San Juan Capistrano. The latest gift of $50 ...

GlaxoSmithKline Pharmaceuticals Limited is ... cephalexin was commenced at Ankleshwar and the salbutamol inhalers at Nashik. Glaxo rated amongst the first five of Indias most respected companies ...

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...